*The FDA has not approved intravenous ketamine or NAD+ for the treatment of any psychiatric or pain condition. These articles reference off-label use. Like all medical treatments, the discussed therapies carry risks and benefits. Speak with a doctor at Clarus Health to learn if these therapies may be right for you.
Ketamine is a promising treatment from chronic fatigue syndrome, or myalgic encephalomyelitis (ME/CFS) - learn more about IV Ketamine and NAD+ for ME/CFS
Nearly 2% of the population is affected by myalgic encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS). There is also significant overlap with long-COVID, which affects 10% of patients with COVID. This is a debilitating condition that physicians know very little about. Learn more about ME/CFS and how IV Ketamine therapy can be a promising therapy for this challenging condition.
ME/CFS is described as a persistent fatigue that is not improvement by rest and sleep. The exhaustion is often exacerbated by physical or mental activity and persists for months. Routine lab tests and MRIs do not show abnormalities, leading many some people to believe it "is all in your head." We don't always know what triggers ME/CFS, but it can be preceded by:
The symptoms of ME/CFS can include:
Interestingly, women are affected more often than men. While NAD+ therapy is effective for many of our ME/CFS patients, there are few other effective treatments. This makes emerging treatments like IV Ketamine very important for those struggling with ME/CFS.
Ketamine is a powerful anesthetic and pain-relieving medication. It is not related to opioids, classical anesthetics, or other pain-killers. Ketamine has several important characteristics that are believed to help treat patients with ME/CFS:
Ketamine is an antagonist of the NMDA receptor and increases levels of presynaptic release of glutamate. The extra glutamate is then shunted towards the AMPA receptor (because the NMDA receptors are blocked by ketamine). This may explain the biochemical anti-fatigue effect of ketamine.
Interestingly, while some studies show the anti-fatigue benefits of ketamine are related to its anti-depressant effects, some studies show independent effects of ketamine in improving both outcomes.
In some studies, anti-fatigue effects occurred within days. In other studies, anti-fatigue effects took several weeks to become stronger.
NAD+ therapy provides many benefits to patients struggling with chronic fatigue. NAD+ therapy can be combined with IV Ketamine for convenient and synergistic improvements in mood and energy levels.
Ketamine comes in many forms, from most-to-least efficient:
IV Ketamine is the gold standard for ketamine therapy because of its 100% bioavailability. Oral ketamine has low bioavailability, around 30%. IV Ketamine allows for significantly more effective symptom relief compared to other forms Ketamine therapy because of its unique intravenous administration.
You deserve to find healing from chronic fatigue and to regain your peak mood and energy. Ketamine therapy, especially when combined with NAD+ therapy, may provide a break in your symptom relief. It is important to speak with your doctor about the benefits and risks of IV Ketamine and NAD+ therapy. Schedule a free consultation with Clarus Health to learn if IV Ketamine Therapy may be effective in restoring your energy levels.